Shockwave Medical (SWAV) Tops Q3 EPS by 5c, Revenues Beat; FY19 Revenue Guidance Above Consensus
Tweet Send to a Friend
Shockwave Medical (NASDAQ: SWAV) reported Q3 EPS of ($0.46), $0.05 better than the analyst estimate of ($0.51). Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
